Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.544 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.489 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.488 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.544 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.488 |
CLV_PCSK_PC1ET2_1 | 30 | 32 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.471 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.576 |
DOC_CKS1_1 | 16 | 21 | PF01111 | 0.628 |
DOC_MAPK_gen_1 | 30 | 38 | PF00069 | 0.547 |
DOC_MAPK_gen_1 | 39 | 47 | PF00069 | 0.464 |
DOC_WW_Pin1_4 | 15 | 20 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.521 |
LIG_14-3-3_CanoR_1 | 39 | 44 | PF00244 | 0.552 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.556 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.549 |
LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.435 |
LIG_LIR_Gen_1 | 49 | 59 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 56 | 62 | PF02991 | 0.417 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.636 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.337 |
LIG_SH2_STAP1 | 10 | 14 | PF00017 | 0.689 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.414 |
MOD_CDK_SPK_2 | 25 | 30 | PF00069 | 0.557 |
MOD_CDK_SPxK_1 | 25 | 31 | PF00069 | 0.554 |
MOD_CDK_SPxxK_3 | 25 | 32 | PF00069 | 0.552 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.637 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.699 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.557 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.708 |
MOD_PKA_1 | 39 | 45 | PF00069 | 0.551 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.559 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.551 |
MOD_ProDKin_1 | 15 | 21 | PF00069 | 0.563 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.519 |
MOD_SUMO_for_1 | 52 | 55 | PF00179 | 0.485 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.637 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.465 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.489 |
TRG_NLS_MonoCore_2 | 29 | 34 | PF00514 | 0.530 |
TRG_NLS_MonoExtC_3 | 30 | 35 | PF00514 | 0.525 |
TRG_NLS_MonoExtN_4 | 29 | 35 | PF00514 | 0.527 |
TRG_Pf-PMV_PEXEL_1 | 50 | 55 | PF00026 | 0.533 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I230 | Leptomonas seymouri | 88% | 100% |
A0A0S4JJA2 | Bodo saltans | 71% | 100% |
A0A3S7X7Y9 | Leishmania donovani | 93% | 100% |
A4IA10 | Leishmania infantum | 93% | 100% |
C9ZMM4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 78% | 100% |
E9B517 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4Q2W9 | Leishmania major | 93% | 100% |